Download PDF
Kardiologie up2date 2006; 2(3): 303-314
DOI: 10.1055/s-2006-944798
Bildgebung und interventionelle Techniken
© Georg Thieme Verlag KG Stuttgart · New York

Vorhofseptumdefekte: Pathophysiologie und Differenzialindikation zur operativen und interventionellen Therapie

Martin  Braun, Steffen  Schoen, Alessandra  Boscheri, Ruth  H.  Strasser
Further Information

Publication History

Publication Date:
05 October 2006 (online)

Also available at
    Permissions and Reprints All articles of this category

Kernaussagen

Ein hämodynamisch relevanter Vorhofseptumdefekt sollte unabhängig vom Alter prinzipiell verschlossen werden. Aufgrund ihrer dezentralen und randständigen Lage im interatrialen Septum sind der ASD-Typ I und der Sinus-venosus-Defekt i. d. R. nur chirurgisch zu behandeln, wobei beim ASD-Typ II v. a. der Katheterverschluss mittels Implantat (Schirm) als Alternative zur Chirurgie zuerst in Betracht gezogen werden sollte. Die wesentlichen anatomischen Voraussetzungen für das erfolgreiche Einbringen eines solchen Verschlusssystems sind Faktoren, wie eine durch das Ballonsizing gemessene Defektgröße < 38 mm, ein ausreichender aortaler Randsaum von 4-5 mm und ein suffizienter Abstand des zu implantierenden Schirmchens zur atrioventrikulären Klappenebene. Die Indikation zum primären medikamentösen Therapieansatz liegt vor bei asymptomatischen Patienten ohne rechtsventrikuläre Belastungszeichen und kleinem ASD oder bei Patienten mit großem ASD und vorliegender Shuntumkehr im Rahmen einer Eisenmenger-Reaktion, bei denen eine Kontraindikation zum ASD-Verschluss besteht.

Literatur

  • 1 Siltanen P. Atrial septal defect of secundum type in adults. Clinical and haemodynamic studies of 129 cases before and after surgical correction under cardiopulmonary bypass.  Acta Med Scand Suppl.. 1968;  497 1-151
    PubMedGoogle Scholar
  • 2 Moss A J. Heart disease in infants, children and adolescents including the fetus and the young. 5 ed. Baltimore; Williams and Wilkins 1995: 60-70, 689-701
    Google Scholar
  • 3 Campbell M. Natural history of atrial septal defect.  Br Heart J. 1970;  32 820-826
    CrossrefPubMedGoogle Scholar
  • 4 Langmann J. Medizinsche Embryologie. Stuttgart; Thieme 1998
    Google Scholar
  • 5 Hara H, Virmani R, Ladich E, Mackey-Bojack S, Titus J, Reisman M, Gray W, Nakamura M, Mooney M, Poulose A, Schwartz R S. Patent foramen ovale: Current pathology, pathophysiology and clinical status.  J Am Coll Cardiol. 2005;  46 1768-76
    CrossrefPubMedGoogle Scholar
  • 6 Friedmann W F. Heart Disease. A Textbook of Cardiovascular Medicine. 5th ed. Philadelphia; Saunders 1997
    Google Scholar
  • 7 Konstantinides S, Geibel A, Kasper W, Just H. The natural course of atrial septal defect in adults - a still unsettled issue.  Klin Wochenschr. 1991;  69 506-510
    CrossrefPubMedGoogle Scholar
  • 8 Gault J H, Gay W A, Ross J. Atrial septal defect over the age of fourty years: clinical and hemodynamic studies and the effects of operation.  Circulation. 1968;  37 261-272
    PubMedGoogle Scholar
  • 9 Graham T P. Ventricular performance in congenital heart disease.  Circulation. 1991;  84 2259-2274
    PubMedGoogle Scholar
  • 10 Booth D C, WisenbaughT , Smith M, DeMaria A N. Left ventricular distensibility and passive elastic stiffness in atrial septal defect.  J Am Coll Cardiol. 1988;  12 1231-1236
    PubMedGoogle Scholar
  • 11 Schubert S, Peters B, Abdul-Khaliq H, Nagdyman N, Lange P E, Ewert P. Left ventricular conditioning in the elderly patient to prevent congestive heart failure after transcatheter closure of atrial septal defect.  Catheter Cardiovasc Interv. 2005;  64 333-337
    CrossrefPubMedGoogle Scholar
  • 12 Perloff J K. Ostium secundum atrial septal defect - survival for 87 and 94 years.  Am J Cardiol. 1984;  53 388-389
    CrossrefPubMedGoogle Scholar
  • 13 Dalen J E, Haynes F W, Dexter L. Life expectancy with atrial septal defect. Influence of complicating pulmonary vascular disease.  JAMA. 1967;  200 442-446
    CrossrefPubMedGoogle Scholar
  • 14 Markman P, Howitt G, Wade E G. Atrial septal defect in the middle-aged and elderly.  Q J Med. 1965;  34 409-426
    PubMedGoogle Scholar
  • 15 Adams C W. A reappraisal of life expectancy with atrial shunts of the secundum type.  Dis Chest. 1965;  48 357-375
    PubMedGoogle Scholar
  • 16 Figueroa M I, Balaguru D, McClure C, Kline C H, Radtke W A, Shirali G S. Experience with use of multiplane transesophageal echocardiography to guide closure of atrial septal defects using the amplatzer device.  Pediatr Cardiol. 2002;  23 430-436
    CrossrefPubMedGoogle Scholar
  • 17 Mazic U, Gavora P, Masura J. The role of transesophageal echocardiography in transcatheter closure of secundum atrial septal defects by the Amplatzer septal occluder.  Am Heart J. 2001;  142 482-488
    CrossrefPubMedGoogle Scholar
  • 18 Holmvang G, Palacios I F, Vlahakes G J. et al . Imaging and Sizing of Atrial Septal Defects by Magnetic Resonance.  Circulation. 1995;  92 3473-3480
    PubMedGoogle Scholar
  • 19 Therrien J, Warnes C, Daliento L. et al . Canadian Cardiovascular Society Consensus Conference 2001 update: recommendations for the management of adults with congenital heart disease part III.  Can J Cardil. 2001;  17 1135-1158
    PubMedGoogle Scholar
  • 20 Attie F, Rosas M, Granados N, Zahal C, Buendia A, Calderon J. Surgical treatment for secundum atrial septal defects in patients > 40 years old. A randomized clinical trial.  J Am Coll Cardiol. 2001;  38 2035-2042
    CrossrefPubMedGoogle Scholar
  • 21 Brochu M C, Baril J F, Dore A, Juneau M, De Guise P, Mercier L A. Improvement in exercise capacity in asymptomatic and mildly symptomatic adults after atrial septal defect percutaneous closure.  Ciurculation. 2002;  106 1821-1826
    PubMedGoogle Scholar
  • 22 Dickinson D F, Arnold R, Wilkinson J L. Congenital heart disease among 160 480 liveborn children in Liverpool 1960 to 1969. Implications for surgical treatment.  Br Heart J. 1981;  46 55-62
    PubMedGoogle Scholar
  • 23 Weber M, Neumann T, Rau M. et al . Cardiopulmonary exercise capacity increases after interventional ASD-closure.  Z Kardiol. 2004;  93 209-215
    PubMedGoogle Scholar
  • 24 Liang T, XiaoJun Z, XiaoJing M, Yun L, Leng C Y. New minimally invasive technique to occlude secundum atrial septal defect in 53 patients.  Ann Thorac Surg. 2006;  81 1417-1419
    CrossrefPubMedGoogle Scholar
  • 25 Konstantinides S, Geibel A, Olschewski M. et al . A comparison of surgical and medical therapy for atrial septal defect in adults.  N Engl J Med. 1995;  333 469-473
    CrossrefPubMedGoogle Scholar
  • 26 King T D, Thompson S L, Steiner C, Mills N L. Secundum atrial septal defect. Nonoperative closure during cardiac catheterization.  JAMA. 1976;  235 2506-2509
    CrossrefPubMedGoogle Scholar
  • 27 Post M C, Suttorp M J, Jaarsma W, Plokker H W. Comparison of outcome and complications using different types of devices for percutaneous closure of a secundum atrial septal defect in adults: a single-center experience.  Catheter Cardiovasc Interv. 2006;  67 438-443
    PubMedGoogle Scholar
  • 28 LaRosee K L, Krause D, Becker M, Beuckelmann D J, Deutsch H J, Höpp H W. Katheterinterventioneller Verschluss von Vorhofeptumdefekten im Erwachsenenalter.  Dtsch Med Wochenschrift. 2001;  126 1030-1036
    Article in Thieme ConnectPubMedGoogle Scholar
  • 29 Eicken A, Witsenburg M, Sebening W, Cromme-Dijkhuis A C, Vogt M, Henze R, Hess J. Katheterinterventioneller Verschluss des Vorhofeptumdefektes vom Sekundumtyp-Erfahrungen mit „CardioSeal” und „Angel Wings”.  Z Kardiol. 1999;  88 1015-1022
    CrossrefPubMedGoogle Scholar
  • 30 Brockmeier K, Schmidt K G, Ulmer H E, Goernflo M. Occlusion of interatrial communications with the Amplatzer device: experience in 48 consecutive patients.  J Interv Cardiol. 2001;  14 325-328
    PubMedGoogle Scholar
  • 31 Chessa M, Carminati M, Butera G. et al . Early and late complications associated with transcatheter occlusion of secundum atrial septal defect.  J Am Coll Cardiol. 2002;  39 1061-1065
    CrossrefPubMedGoogle Scholar
  • 32 Lopez K, Dalvi B V, Balzer D, Bass J L, Momenah T, Cao Q L, Hijazzi Z M. Transcatheter closure of large secundum atrial septal defects using the 40 mm Amplatzer septal occluder: results of an international registry.  Catheter Cardiovasc Interv. 2005;  66 580-584
    PubMedGoogle Scholar
  • 33 Fischer G, Stieh J, Uebing A, Hoffmann U, Morf G, Kramer H H. Experience with transcatheter closure of secundum atrial septal defects using the Amplatzer septal occluder: a single centre study in 236 consecutive patients.  Heart. 2003;  89 199-204
    CrossrefPubMedGoogle Scholar
  • 34 Braun M U, Fassbender D, Schoen S P, Haass M, Schraeder R, Scholtz W, Strasser R H. Transcatheter closure of patent foramen ovale in patients with cerebral ischemia.  J Am Coll Cardiol. 2002;  39 2019-2025
    PubMedGoogle Scholar
  • 35 Braun M U, Gliech V, Boscheri A. et al . Transcatheter closure of patent foramen ovale (PFO) in patients with paradoxical embolism. Periprocedural safety and mid-term follow-up results of three different device occluder systems.  Eur H J. 2004;  25 424-430
    CrossrefPubMedGoogle Scholar
  • 36 Giardini A, Donti A, Formiagari R. et al . Determinants of cardiopulmonary functional improvement after transcatheter atrial septal defect closure in asymptomatic adults.  J Am Coll Cardiol. 2004;  43 1886-1891
    CrossrefPubMedGoogle Scholar
  • 37 Dhillon R, Josen M, Henein M, Redington A. Transcatheter closure of atrial septal defect preserves right ventricular function.  Heart. 2002;  87 461-465
    CrossrefPubMedGoogle Scholar
  • 38 Eidem B W, O’Leary P W, Tei C, Seward J B. Usefulness of the myocardial performance index for assessing right ventricular function in congenital heart disease.  AmJ Cardiol. 2000;  86 654-685
    CrossrefPubMedGoogle Scholar
  • 39 Schoen S P, Kittner T, Bohl S, Braun M U, Simonis G, Schmeisser A, Strasser R. Transcatheter closure of atrial septal defects improves right ventricular volume, mass, function, pulmonary pressure, and functional class: a magnetic resonance imaging study.  Heart. 2006;  92 821-826
    CrossrefPubMedGoogle Scholar
  • 40 Salehian O, Horlick E, Scherzmann M. et al . Improvements in cardiac form and function after transcatheter closure of secundum atrial septal defects.  J Am Coll Cardiol. 2005;  45 499-504
    CrossrefPubMedGoogle Scholar
  • 41 DiSalvo , Drago M, Pacileo G. et al . Comparison of strain rate imaging for quantitative evaluation of regional left and right ventricular function after surgical versus percutaneous closure of atrial septal defect.  Am J Cardiol. 2005;  96 299-302
    CrossrefPubMedGoogle Scholar
  • 42 Butera G, Carminati M, Chessa M. et al . Percutaneous versus surgical closure of secundum atrial septal defect: comparison of early results and complications.  Am Heart J. 2006;  151 228-234
    CrossrefPubMedGoogle Scholar

Dr. med. habil. Martin Braun

Medizinische Klinik/Kardiologie
Technische Universität Dresden

Fetscherstraße 76
01309 Dresden

Email: Martin.Braun@mailbox.tu-dresden.de

      >